A Pragmatic Trial To Determine the Benefit of Exercise Incentives and Corticosteroid Injections in Osteoarthritis of the Knee
MOVE-OK
A Pragmatic Trial to Determine the Benefit of Exercise Incentives and Corticosteroid Injections for Osteoarthritis of the Knee
1 other identifier
interventional
34
1 country
1
Brief Summary
Knee osteoarthritis (KOA) is one of the most common and disabling conditions among Veterans. Management of KOA is challenging as there are few effective treatments other than joint replacement. Importantly, low levels of physical activity in patients with knee problems might worsen pain and disability. This study aims to determine the feasibility of using methods to change behavior that use social incentives and promote physical activity through playing games and interacting with a web-based platform. The study will also evaluate an important and widely used treatment, namely corticosteroid injections. Participants will be randomized into one of 4 arms and will receive a different combination of social incentives and injections. The study will evaluate which approach is most effective at promoting physical activity and reducing pain and disability.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 7, 2019
CompletedFirst Posted
Study publicly available on registry
February 11, 2019
CompletedStudy Start
First participant enrolled
July 8, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2021
CompletedJuly 27, 2021
July 1, 2021
1.8 years
February 7, 2019
July 26, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percent change from baseline in weekly average steps per day
Steps measured by a wearable activity monitor
Measured weekly over 3-10 months
Secondary Outcomes (3)
Change in Knee Injury and Osteoarthritis Outcome Score (KOOS)
Measured bi-weekly over 3-10 months
Change in PROMIS pain intensity score
Measured bi-weekly over 3-10 months
Change in PROMIS Fatigue
Measured every 4 weeks over 3-10 months
Study Arms (4)
Social Incentives and Gamification, Corticosteroid AB
EXPERIMENTALParticipants will receive a support person and be able to interact with a web-based platform to progress through levels based on their achievement of step goals. The participants will receive injections in A-B order (corticosteroids, then lidocaine only)
No Incentive, Corticosteroid AB
ACTIVE COMPARATORParticipants will only receive reminders to sync their activity monitor. The participants will receive injections in A-B order (corticosteroids, then lidocaine only)
Social Incentives and Gamification, Corticosteroid BA
EXPERIMENTALParticipants will receive a support person and be able to interact with a web-based platform to progress through levels based on their achievement of step goals. The participants will receive injections in B-A order (lidocaine only, then corticosteroids)
No Incentive, Corticosteroid BA
ACTIVE COMPARATORParticipants will only receive reminders to sync their activity monitor. The participants will receive injections in B-A order (lidocaine only, then corticosteroids)
Interventions
The intervention will provide social incentives and gamification to promote physical activity.
The study will compare corticosteroid injections with lidocaine to lidocaine only in a crossover design. These participants will receive the medication in A-B order.
No social incentive will be applied
The study will compare corticosteroid injections with lidocaine to lidocaine only in a crossover design. These participants will receive the medication in B-A order.
Eligibility Criteria
You may qualify if:
- Veterans in VA Rheumatology or Orthopedic clinics
- Chronic knee osteoarthritis
- Indication for joint injection
- Previous joint injections for palliation
- Patient expresses interest in increasing their physical activity
- Patient is able to walk 1/2 mile per day
You may not qualify if:
- Intra-articular hardware or other contraindication to joint injection
- Lack of smart phone
- Acute exacerbation of osteoarthritis or knee pain
- Unable or unwilling to identify a social sponsor
- Comorbid condition that precludes safe exercise
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
Philadelphia, Pennsylvania, 19104, United States
Related Publications (2)
Gillcrist RL, Doherty CR, Olave M, Bonilla J, England BR, Wysham K, Quinones M, Scanzello CR, Ogdie A, White DK, Neogi T, Baker JF. A Remote Behaviorally Designed Intervention to Promote Physical Activity in Patients With Knee Osteoarthritis: Results of a Pilot Randomized Clinical Trial. J Clin Rheumatol. 2024 Dec 1;30(8):336-339. doi: 10.1097/RHU.0000000000002148. Epub 2024 Oct 16.
PMID: 39412672DERIVEDBaker JF, Olave M, Leach W, Doherty CR, Gillcrist RL, White DK, Ogdie A, England BR, Wysham K, Quinones M, Xiao R, Neogi T, Scanzello CR. Corticosteroid Injections for Symptomatic Treatment of Osteoarthritis of the Knee: A Pilot Blinded Randomized Trial. ACR Open Rheumatol. 2023 Oct;5(10):529-535. doi: 10.1002/acr2.11596. Epub 2023 Sep 22.
PMID: 37740448DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joshua F. Baker, MD MSCE
Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- It is not possible to blind participants to the social incentives they will receive. For the injection aspect of the study, the investigator will be aware of the injection being given but the syringe will be covered to obscure the view of the patient.
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 7, 2019
First Posted
February 11, 2019
Study Start
July 8, 2019
Primary Completion
May 1, 2021
Study Completion
June 30, 2021
Last Updated
July 27, 2021
Record last verified: 2021-07
Data Sharing
- IPD Sharing
- Will not share